Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)
| Market Cap | 164.16M-8.3% |
| Revenue (ttm) | 0 |
| Net Income | -101.90M-75.8% |
| EPS | -6.48-36.1% |
| Shares Out | 18.53M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,003,667 |
| Open | 10.38 |
| Previous Close | 10.60 |
| Day's Range | 8.84 - 10.38 |
| 52-Week Range | 7.12 - 20.56 |
| Beta | 2.64 |
| Analysts | Buy |
| Price Target | 33.67(+280.02%) |
| Earnings Date | Nov 11, 2026 |
About CRBP
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CRBP stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in CRBP holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CRBP's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CRBP Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CRBP Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Other drug development | $2.47M | 68.19% |
| Other income, net | $1.15M | 31.81% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CRBP patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CRBP from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CRBP
| ETF | Est. Holding Size |
|---|---|
| IWMiShares Russell 2000 ETF | $4.84M |
| VTIVanguard Morningstar Total Stock Market ETF | $4.79M |
| IWNiShares Russell 2000 Value ETF | $1.78M |
| VXFVanguard Extended Market ETF | $1.77M |
| FESMFidelity Enhanced Small Cap ETF | $927.20K |
| VTWOVanguard Russell 2000 ETF | $832.19K |
Estimated from each fund’s disclosed top holdings × AUM
CRBP Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CRBP’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score